EDIT
Editas Medicine Inc
2.80$
+0.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -664.5% | -37.0% | -4,394.0% | -11,123.2% | -86,209.8% | -165.9% | -1,026.2% | -1,403.4% | -408.9% | -147.1% | -814.6% | -248.7% | -255.0% | |
| 28.4% | 2.4% | 124.1% | 276.8% | 2,621.3% | 4.5% | 41.2% | 44.1% | 9.6% | 5.6% | 17.1% | 3.5% | 6.4% | |
| 88.7% | 8.9% | 668.3% | 976.6% | 7,872.1% | 13.1% | 64.0% | 74.5% | 29.5% | 8.6% | 74.2% | 18.4% | 18.4% | |
| 65.3% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 85.5% | -13.5% | 422.9% | 1,249.5% | 7,113.1% | -39.5% | 378.2% | -129.1% | -146.0% | -134.2% | -65.2% | -124.9% | -129.6% | |
| 4.5% | 2.2% | 164.8% | 681.1% | 4,788.5% | 1.8% | 2.4% | 0.0% | 5.7% | 0.2% | 3.2% | 0.9% | 1.5% | |
| -1,926.9% | 104.6% | -418.1% | 10,127.5% | 137,670.5% | 101.2% | 1,210.5% | 1,192.0% | 524.6% | 0.2% | 2.3% | -250.6% | 21.1% | |
| – | – | – | – | 527.9% | – | – | 6.4% | – | -0.9% | – | – | – | |
| 0.0% | 0.9% | 16.9% | 62.8% | 0.0% | 181.4% | -30.9% | 207.2% | 227.6% | 70.0% | 0.0% | 988.5% | 323.4% | |
| -2,591.4% | 68.5% | -4,795.2% | -932.9% | 51,460.7% | 116.7% | 153.5% | -4.2% | 343.4% | -76.8% | -812.3% | 489.2% | 89.5% | |
| -669.0% | -39.2% | -4,558.9% | -11,804.3% | -90,998.4% | -167.6% | -1,028.6% | -1,403.4% | -414.6% | -147.3% | -817.8% | -249.6% | -256.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.